IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pivotal bioVenture Partners Investment Advisor LLC

Q4 2021 Holdings

Filed 2022-02-14 | 10 holdings | $12.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$11.8M569,04198.1%
Karuna Therapeutics IncCOM48576A100$111.7K852,7080.9%
Vaxcyte Inc(PCVX)COM92243G108$26.4K1,111,4850.2%
Rallybio CorpCOM75120L100$21.7K2,271,3110.2%
Exscientia PLCADS30223G102$15.3K772,2850.1%
Akouos IncCOM00973J101$15.3K1,794,0880.1%
Inozyme Pharma IncCOM45790W108$10.9K1,591,1540.1%
Aligos Therapeutics IncCOM01626L105$10.4K876,5480.1%
Bolt Biotherapeutics Inc(BOLT1EUR)COM097702104$9.3K1,891,4670.1%
Fusion Pharmaceuticals IncCOM36118A100$6.5K1,598,3770.1%